Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07084142 · ClinicalTrials.gov registry record · NA
Developing a Digital Aid to Improve ICD Decisions
A NA study of Heart Failure and Reduced Ejection Fraction, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 2
- Study locations
NCT07084142 is a NA study of Heart Failure and Reduced Ejection Fraction that is actively recruiting participants, run by Stanford University. The registered enrollment target is 600 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07084142, a NA study of Heart Failure and Reduced Ejection Fraction, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 2
- Study locations
Study Summary
Advanced heart failure, affecting 7 million Americans, has multiple causes and results in greatly increased risk of disability and death. A major problem is sudden cardiac death, when the damaged heart develops an abnormal pattern of electrical conduction that can result in cessation of heart activity. While placement of an Implantable Cardioverter-Defibrillator (ICD) in a patient's chest can help prevent sudden cardiac death, these devices have several important downsides. This protocol focuses on development of a digital decision aid that helps heart failure patients make informed decisions that balance the benefits and downsides of ICD placement. This protocol covers the use of participant surveys, focus groups, and interviews to obtain the needed background information to guide the development of this digital tool, which will be subsequently tested against usual care in a randomized clinical trial. The study design is best described as a mixed methods evaluation and refinement of a digital app to improve ICD decision-making. In the future, the present protocol will be modified to create a new protocol that covers the needed human subjects requirements for performance of this clinical trial.
Conditions Studied
Interventions
- OTHER Online, patient-facing decision-making aid (app) with personalized risk information.
- DEVICE Implantable Cardioverter Defibrillator (ICD)
- OTHER Online, patient-facing decision-making app without personalized risk information.
Study Locations (2)
California
- University of California, San Francisco - San Francisco
North Carolina
- Eastern Carolina University - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-08 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07084142
The ClinicalTrials.gov registry entry for NCT07084142 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure and Reduced Ejection Fraction appearing as the primary indexed condition, and to 3 interventions - of which Online, patient-facing decision-making aid (app) with personalized risk information. is the first listed.
NCT07084142 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT07084142 about?
NCT07084142 is a clinical study titled "Developing a Digital Aid to Improve ICD Decisions". Advanced heart failure, affecting 7 million Americans, has multiple causes and results in greatly increased risk of disability and death. A major problem is sudden cardiac death, when the damaged heart develops an abnormal pattern of electrical conduction that can result in cessation of heart activi...
What is the current status of trial NCT07084142?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2025-08. Estimated completion is 2026-06.
What conditions does trial NCT07084142 study?
This clinical trial studies the following conditions: Heart Failure and Reduced Ejection Fraction.
What interventions are being tested in trial NCT07084142?
The interventions under investigation include: Online, patient-facing decision-making aid (app) with personalized risk information. (OTHER), Implantable Cardioverter Defibrillator (ICD) (DEVICE), Online, patient-facing decision-making app without personalized risk information. (OTHER).
Who is sponsoring clinical trial NCT07084142?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07084142 being conducted?
This trial has 2 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure and Reduced Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.